← Back to Search

Behavioural Intervention

Study group for Tic Disorder

N/A
Recruiting
Led By Christine Conelea, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment)
Awards & highlights

Study Summary

This trial aims to study a treatment called CBIT for chronic tics, which are involuntary movements or sounds. CBIT focuses on helping patients control their tics by learning alternative actions. The study will

Who is the study for?
This trial is for young people aged 12-21 with chronic motor and/or vocal tics, which have lasted at least a year without a break of more than three months. Participants should have moderate tic severity as measured by the Yale scale, an IQ over 70, and must understand English well.Check my eligibility
What is being tested?
The study tests CBIT (Comprehensive Behavioral Intervention for Tics), focusing on increasing control over tics through competing response training. The treatment's effectiveness will be monitored across eight sessions using video recordings and assessments of behavior and overall functioning.See study design
What are the potential side effects?
CBIT is a non-medical therapy focused on behavior modification rather than medication; therefore, it typically does not involve drug-related side effects. However, participants may experience fatigue or frustration during the learning process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ask Suicide-Screening Questions (ASQ)
Behavior Rating Inventory of Executive Function
Caregiver Strain Questionnaire
+6 more
Secondary outcome measures
Premonitory Urge for Tics Scale
Stop signal task
Tic Suppression Task

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study groupExperimental Treatment1 Intervention
Youth ages 12-21 years with chronic tics will complete a course of 10 outpatient, weekly CBIT sessions with pre-, post-, 1-month and 3-month follow up assessments.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,391 Previous Clinical Trials
1,553,114 Total Patients Enrolled
Christine Conelea, PhDPrincipal InvestigatorUniversity of Minnesota
3 Previous Clinical Trials
146 Total Patients Enrolled
~20 spots leftby Mar 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top